Author
Pedro Ruivo
The Netherlands Cancer InstitutePrimary ORCID profile (0000-0002-5419-4790 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Same name, identified by ORCID
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2026-2026 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 24 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship2 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
CCR2 is a potential biomarker and therapeutic target in Group 3 medulloblastoma
Carlos Custodia, Rita Cascão, Eunice Paisana…·Claudia C Faria
This study identifies CCR2 as a biomarker and therapeutic target in Group 3 medulloblastoma, showing its association with dissemination and poor survival, and demonstrating therapeutic efficacy through Cenicriviroc.
DOI 10.64898/2026.10.11.757412